Veracyte | VCYT - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Agenus USD 33.7M 500K 2026-03
Agilent USD 1.88B 43M 2026-06
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Illumina USD 1.16B 70M 2026-06
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Laboratory Of America USD 3.73B 190M 2026-06
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Siemens EUR 20.79B 1.03B 2026-06
Sonic Healthcare AUD 5.42B 30M 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Veracyte USD 150.32M 11.25M 2026-06
Waters USD 1.64B 370M 2026-06